It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK
A total of 707 district hospitals across all states and union territories participated in the performance assessment. The Health Management Information System (HMIS) data for the year 2017–18 has been used as a baseline for this exercise
Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
It becomes the first ophthalmology biosimilar to gain FDA approval in the United States
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
The Bidar API manufacturing facility of Sai Life Sciences has been on a path of significant expansion with its production capacity growing from 200KL in 2017 to 450KL
New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson Covid-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination.
Subscribe To Our Newsletter & Stay Updated
